It is possible that the CD44 antibodies used here work by more than one discrete mechanism in arthritis, with different antibodies falling into different classes of effector molecules or that the antibodies may of course all work by different unrelated mechanisms. This evidence concerns the gene CD44 and arthritic joint disease.